Cogent Biosciences Stock Soars: A Year of Gains and a $4.5M Sell
Cogent Biosciences has delivered staggering gains in a single year, yet a major fund recently trimmed its stake by mi...
Value-oriented index funds offer efficient exposure for retirement accounts. Review 2024 picks and what to check before investing.
24,226 articlesCogent Biosciences has delivered staggering gains in a single year, yet a major fund recently trimmed its stake by mi...
Polychain Capital has secured a $200 million first close for its fourth crypto fund, with plans to reach roughly $400...
A hypothetical move where Paramount aligns with Warner Bros. Discovery would ripple through streaming, financing, and...
A leading life sciences supplier has seen its stock fall sharply over the past year. At the same time, a hedge fund s...
In investing, some smaller players can outpace giants. This guide shows how to evaluate whether this fish should outp...
Micron stock has surged dramatically, but savvy investors are asking: is it still a bargain? This article breaks down...
The next Fed chair choice could redefine the market landscape. This article breaks down what president donald trump's...
A high-profile clash over AI in music doubles as a money lesson. Discover practical ways to protect earnings, invest ...
Cerebras burst onto the public market with a splashy IPO, but a strong first day doesn’t guarantee long-term gains. T...
Citigroup has quietly strengthened its fundamentals while stock performance has turned a corner. This guide breaks do...
A hedge fund trend today centers on a lean, two-name portfolio. INDUS Capital Partners boosted its bet on H World Gro...
Greg Abel is stepping into a part of the market Warren Buffett mostly left untouched. This article breaks down what A...